Clinical trial
Efficacy and Safety/Tolerability of Grass MATA MPL
NCT00414141 · Allergy Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00414141 |
|---|---|
| Title | Efficacy and Safety/Tolerability of Grass MATA MPL |
| Official title | Efficacy and Safety/Tolerability of Grass MATA MPL, a Randomized, Placebo-Controlled, Double-Blind Study |
| Lead sponsor | Allergy Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type I Hypersensitivity |
| Intervention type | Biological |
| Interventions | Grass MATA MPL, Placebo |
| Enrollment | 1,028 |
| Start date | Nov 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Dec 21, 2006 |
| Last update posted | Jun 17, 2010 |
| Countries | Austria, Canada, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: